ebook: How FBDD improves hit rates & delivers high-value targets
Posted: 8 June 2020 | NanoTemper Technologies | No comments yet
Learn how fragment-based drug discovery improves hit rates and delivers higher-value targets using various biophysical methods.
Learn the basics of fragment-based drug discovery, one of the most valuable approaches to small molecule screening. In particular, find out how various biophysical methods are used to improve hit rates and deliver higher-value targets.
Related content from this organisation
- Bispecific antibodies: the next generation of immuno-oncology drugs
- Oncology meets immunology – antibody-mediated regulation of the immune response
- Antibody therapeutics for COVID-19
- Defusing antibody neutralisers in AAV gene therapy
- Expert view: Increasing the efficiency of biologics development: the secret is precise and reliable stability characterisation of candidate molecules
Related topics
Analytical techniques, Assays, Bioinformatics, Biopharmaceuticals, Hit-to-Lead, Lab Automation, Mass Spectrometry, Screening
Related organisations
NanoTemper Technologies